If you know anything about Maison Margiela, the wickedly maverick French fashion house, you’re likely not all that surprised ...

In a maze of plywood artists' studios built into a Dublin warehouse, author and filmmaker Seanan Kerr stitches together a ...

Close to the Canadian border, some Minnesota residents are sounding the environmental alarm over an end to the mortai ...

This guide is not “M&A for Dummies.” It’s a practical roadmap for business owners and operators who want a high-level view of ...

Nahda Nabiilah is a writer and editor from Indonesia. She has always loved writing and playing games, so one day she decided to combine the two. Most of the time, writing gaming guides is a blast for ...

After finding Still Water in an outer room behind the West Gate, you'll find yourself in one of the trippier areas in Blue Prince. The Atelier Maze is easily one of the most confusing areas in the ...

I’m sitting in a dimly-lit karaoke booth with Alison Hammond and Sam Ryder with only one question on my mind: What is my life? It’s the start of a chaotic evening promoting Channel 4’s new series, ...

Maze Therapeutics (MAZE) plunged ~37% on Wednesday despite reporting encouraging initial data from a Phase 2 trial for its lead asset, MZE829, targeted at broad APOL1-mediated kidney disease, a ...

Maze Therapeutics has revealed topline phase 2 data for its lead kidney disease candidate that has analysts heralding its “best-in-class potential.” The once-daily oral small molecule APOL1 inhibitor, ...

A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...

Positive topline data from Phase 2 HORIZON trial of MZE829 demonstrating first clinical proof-of-concept in patients with broad AMKD to support advancement into pivotal program; Maze to host ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.